These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27088206)

  • 21. The use of hydroxychloroquine in lupus pregnancy: the British experience.
    Khamashta MA; Buchanan NM; Hughes GR
    Lupus; 1996 Jun; 5 Suppl 1():S65-6. PubMed ID: 8803914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity.
    Desmarais J; Rosenbaum JT; Costenbader KH; Ginzler EM; Fett N; Goodman S; O'Dell J; Pineau CA; Schmajuk G; Werth VP; Link MS; Kovacs R
    Arthritis Rheumatol; 2021 Dec; 73(12):2151-2160. PubMed ID: 34697918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimalarial agents and lupus.
    Wallace DJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 25. Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.
    Wei LC; Chen SN; Ho CL; Kuo YH; Ho JD
    Chang Gung Med J; 2001 May; 24(5):329-34. PubMed ID: 11480331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.
    Kobak S; Deveci H
    Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin and ophthalmic complications of chloroquine and hydroxychloroquine in patients with rheumatoid arthritis and systemic lupus erythematous.
    Zamani B; Hasan-Abad AM; Rafizadeh SM; Akbari H; Motedayyen H
    J Immunoassay Immunochem; 2024 May; 45(3):178-188. PubMed ID: 38722204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
    Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
    J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
    Tzekov R
    Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases.
    Costedoat-Chalumeau N; Hulot JS; Amoura Z; Leroux G; Lechat P; Funck-Brentano C; Piette JC
    Rheumatology (Oxford); 2007 May; 46(5):808-10. PubMed ID: 17202178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discoid lupus erythematosus.
    Brown RK
    Arch Dermatol; 1972 May; 105(5):768-70. PubMed ID: 4537259
    [No Abstract]   [Full Text] [Related]  

  • 32. Keratopathy with low dose chloroquine therapy.
    Cullen AP; Chou BR
    J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Eye toxicity of antimalarial agents].
    Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal Complications in Patients with Systemic Lupus Erythematosus Treated with Antimalarial Drugs.
    Mukwikwi ER; Pineau CA; Vinet E; Clarke AE; Nashi E; Kalache F; Grenier LP; Bernatsky S
    J Rheumatol; 2020 Apr; 47(4):553-556. PubMed ID: 31474597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.
    Ruiz-Irastorza G; Ramos-Casals M; Brito-Zeron P; Khamashta MA
    Ann Rheum Dis; 2010 Jan; 69(1):20-8. PubMed ID: 19103632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic lupus erythematosus therapy. Antimalarials in inflammatory diseases].
    Yebra-Bango M; Tutor-Ureta P
    Rev Clin Esp; 2004 Nov; 204(11):565-6. PubMed ID: 15511401
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
    Parke AL
    J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
    Meinão IM; Sato EI; Andrade LE; Ferraz MB; Atra E
    Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimalarial therapy for lupus erythematosus: an apparent advantage of quinacrine.
    Zuehlke RL; Lillis PJ; Tice A
    Int J Dermatol; 1981; 20(1):57-61. PubMed ID: 7203769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to ophthalmologic monitoring for antimalarial toxicity in a lupus cohort.
    Bernatsky S; Pineau C; Joseph L; Clarke A
    J Rheumatol; 2003 Aug; 30(8):1756-60. PubMed ID: 12913931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.